NAPEPLD and COVID-19: However, the expression of genes encoding enzymes in the AEA pathway, such as NAPE-PLD, was downregulated in GCs-treated patients, indicating that GCs was not responsible for the increased synthesis of AEA in severe/critical COVID-19 patients.